title: Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.
abstract: Recurrent outbreaks of H5, H7 and H9 avian influenza viruses in domestic poultry accompanied by their occasional transmission to humans have highlighted the public health threat posed by these viruses. Newer vaccine approaches for pandemic preparedness against these viruses are needed, given the limitations of vaccines currently approved for H5N1 viruses in terms of their production timelines and the ability to induce protective immune responses in the absence of adjuvants. In this study, we evaluated the feasibility of an adenovirus (AdV)-based multivalent vaccine approach for pandemic preparedness against H5, H7 and H9 avian influenza viruses in a mouse model. Replication-defective AdV vectors expressing hemagglutinin (HA) from different subtypes and nucleoprotein (NP) from one subtype induced high levels of humoral and cellular immune responses and conferred protection against virus replication following challenge with H5, H7 and H9 avian influenza virus subtypes. Inclusion of HA from the 2009 H1N1 pandemic virus in the vaccine formulation further broadened the vaccine coverage. Significantly high levels of HA stalk-specific antibodies were observed following immunization with the multivalent vaccine. Inclusion of NP into the multivalent HA vaccine formulation resulted in the induction of CD8 T cell responses. These results suggest that a multivalent vaccine strategy may provide reasonable protection in the event of a pandemic caused by H5, H7, or H9 avian influenza virus before a strain-matched vaccine can be produced.
authors: Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America.
authors: Sai V
authors: SV
authors: Vemula
authors: Yadvinder S
authors: YS
authors: Ahi
authors: Anne-Marie
authors: AM
authors: Swaim
authors: Jacqueline M
authors: JM
authors: Katz
authors: Ruben
authors: R
authors: Donis
authors: Suryaprakash
authors: S
authors: Sambhara
authors: Suresh K
authors: SK
authors: Mittal
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D002460:Cell Line; D005260:Female; D005822:Genetic Vectors / Q000235:genetics / Q000627:therapeutic use; D006388:Hemagglutinins / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D056724:Immunity, Humoral; D009980:Influenza A virus / Q000235:genetics* / Q000276:immunology; D007252:Influenza Vaccines / Q000235:genetics* / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D009698:Nucleoproteins / Q000235:genetics* / Q000276:immunology; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000517:prevention & control*; D014612:Vaccines
chemical_list: D006388:Hemagglutinins; D007252:Influenza Vaccines; D009698:Nucleoproteins; D014612:Vaccines
references: Nature. 2009 Jun 25;459(7250):1122-5
references: 19516283
references: Lancet. 2008 Nov 29;372(9653):1894-1905
references: 19012957
references: Science. 2011 Aug 12;333(6044):843-50
references: 21737702
references: J Infect Dis. 2008 Sep 1;198(5):635-41
references: 18694338
references: Annu Rev Microbiol. 2005;59:553-86
references: 16153179
references: Expert Rev Mol Med. 2010 Apr 29;12:e14
references: 20426889
references: Hum Gene Ther. 1999 Nov 1;10(16):2667-72
references: 10566894
references: Vaccine. 2009 Mar 18;27(13):1889-97
references: 19368768
references: Vaccine. 2007 Sep 28;25(39-40):6845-51
references: 17728024
references: Vaccine. 2005 Jan 11;23(8):1029-36
references: 15620476
references: J Virol. 2012 Jun;86(11):6179-88
references: 22491456
references: Emerg Infect Dis. 2006 Jan;12(1):48-54
references: 16494717
references: J Infect Dis. 2012 Jun 15;205(12):1806-10
references: 22492863
references: Nat Rev Immunol. 2007 Apr;7(4):267-78
references: 17363960
references: N Engl J Med. 2008 Oct 9;359(15):1631-3
references: 18843132
references: Curr Gene Ther. 2011 Aug;11(4):307-20
references: 21453277
references: Science. 2009 Apr 10;324(5924):246-51
references: 19251591
references: Euro Surveill. 2010 Feb 04;15(5):
references: 20144443
references: Vaccine. 2001 Oct 12;20(1-2):125-33
references: 11567756
references: J Immunol. 2011 Apr 1;186(7):4331-9
references: 21357542
references: Vaccine. 2005 Nov 16;23(46-47):5404-10
references: 16011865
references: Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18979-84
references: 20956293
references: N Engl J Med. 2009 Nov 12;361(20):1945-52
references: 19745214
references: Avian Dis. 2005 Sep;49(3):317-27
references: 16252482
references: J Gen Virol. 2002 Apr;83(Pt 4):723-734
references: 11907320
references: Emerg Infect Dis. 2009 Jun;15(6):859-65
references: 19523282
references: Clin Pharmacol Ther. 2007 Dec;82(6):665-71
references: 17957181
references: Nat Struct Mol Biol. 2009 Mar;16(3):265-73
references: 19234466
references: J Virol. 2002 Jun;76(12):5882-92
references: 12021321
references: Nature. 2012 May 02;486(7403):420-8
references: 22722205
references: Nat Med. 2010 Dec;16(12):1389-91
references: 21135852
references: Clin Vaccine Immunol. 2007 Nov;14(11):1425-32
references: 17913860
references: Mol Ther. 2008 May;16(5):965-71
references: 18301400
references: Science. 2012 Jun 22;336(6088):1534-41
references: 22723413
references: Science. 2010 Aug 27;329(5995):1060-4
references: 20647428
references: N Engl J Med. 1983 Jul 7;309(1):13-7
references: 6602294
references: Virology. 2009 Mar 30;386(1):44-54
references: 19211122
references: Science. 1993 Mar 19;259(5102):1745-9
references: 8456302
references: Lancet. 2006 Feb 11;367(9509):475-81
references: 16473124
references: Vaccine. 2011 Oct 19;29(45):8066-72
references: 21864622
references: Lancet. 2008 Nov 29;372(9653):1881-1893
references: 19012954
references: Curr Opin Virol. 2012 Apr;2(2):134-41
references: 22482710
references: J Clin Invest. 2008 Oct;118(10):3478-90
references: 18802496
references: J Virol. 1993 May;67(5):2552-8
references: 7682624
references: J Virol. 2005 Jun;79(11):6791-800
references: 15890918
references: Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2573-8
references: 22308500
references: Clin Diagn Lab Immunol. 2004 Mar;11(2):351-7
references: 15013987
references: Virus Res. 2004 Oct;105(2):127-36
references: 15351486
references: PLoS One. 2010 Mar 23;5(3):e9812
references: 20352112
references: J Infect Dis. 2008 Apr 15;197(8):1185-8
references: 18462165
references: AIDS. 2011 Jan 14;25(2):153-8
references: 21150554
references: Expert Opin Biol Ther. 2010 Oct;10(10):1469-87
references: 20822477
references: Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9
references: 3872457
references: Poult Sci. 2009 Apr;88(4):872-9
references: 19276438
references: J Immunol. 2008 Sep 15;181(6):4168-76
references: 18768874
references: PLoS One. 2012;7(3):e33428
references: 22432020
references: Vaccine. 2012 Mar 9;30(12):2098-108
references: 22296955